A privileged structure is a molecular scaffold found repeatedly in active compounds and capable of productive binding to multiple protein targets. Medicinal chemists use these historically active scaffolds to reduce the risk of exploring entirely unknown chemical territory during drug discovery. section 1.1.2
Benzodiazepine core
The benzodiazepine core appears in diazepam and alprazolam, which bind GABA receptors. Benzodiazepine-derived compounds have also shown activity against CCK receptors, HIV-1 reverse transcriptase, and various GPCRs. section 1.1.2
Account for two important trade-offs:
- Treat activity across multiple targets as potentially promiscuous, because unwanted binding can cause side effects. section 1.1.2
- Expect related compounds to face greater patenting difficulty because privileged structures have been extensively researched and used in patented drugs. section 1.1.2
